Pulmonary mass
Conditions
Interventions
SARS-CoV-2 infection 5-8 weeks group:None
SARS-CoV-2 infection 9-12 weeks group:None
SARS-CoV-2 infection 13-16 weeks group:None
SARS-CoV-2 infection 5-10 weeks group:None
SARS-CoV-2 infection 11-16 weeks group:None
Sponsors
Affiliated Hospital of Yangzhou University
Eligibility
Sex/Gender
All
Age
25 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients undergoing elective thoracoscopic partial lung resection surgery; 2. Age: 25-75 years old; 3. BMI 18-25kg/m2; 4. ASA Level I or II; 5. Previous history of COVID-19 infection.
Exclusion criteria
Exclusion criteria: 1. Preoperative complications include severe cardiovascular, liver, kidney and other important organ diseases, moderate or above anemia; 2. Moderate or above abnormalities in lung function examination FEV1/FVC<65%; 3. Those who have severe cognitive impairment before surgery and are unable to communicate normally.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| postoperative pulmonary complications;postoperative cognitive function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum inflammatory factors;S100ß protein;Qs/Qt; | — |
Countries
China
Contacts
Public ContactYang Dawei
Affiliated Hospital of Yangzhou University
Outcome results
None listed